688767 博拓生物
已收盘 05-09 15:00:01
资讯
新帖
简况
博拓生物涨5%创近2年新高
智选洞察 · 05-09 05:17
博拓生物涨5%创近2年新高
博拓生物:5月6日高管高红梅减持股份合计6000股
证券之星 · 05-07
博拓生物:5月6日高管高红梅减持股份合计6000股
博拓生物05月06日主力净流入313.5万元 散户资金抛售
市场透视 · 05-06
博拓生物05月06日主力净流入313.5万元 散户资金抛售
迈瑞首现营收净利双降,医疗器械黄金十年终结?
CHC医疗传媒 · 04-30
迈瑞首现营收净利双降,医疗器械黄金十年终结?
博拓生物04月29日主力净流入46万元 散户资金抛售
市场透视 · 04-29
博拓生物04月29日主力净流入46万元 散户资金抛售
博拓生物:2024年业绩斩获高增长,产业布局未来可期
览富财经 · 04-27
博拓生物:2024年业绩斩获高增长,产业布局未来可期
博拓生物2024年归母净利润增59%至1.7亿元
财中社 · 04-27
博拓生物2024年归母净利润增59%至1.7亿元
博拓生物(688767)2025年一季报简析:净利润减77.97%,三费占比上升明显
证券之星 · 04-26
博拓生物(688767)2025年一季报简析:净利润减77.97%,三费占比上升明显
博拓生物(688767)3月31日股东户数0.62万户,较上期减少2.11%
证券之星 · 04-26
博拓生物(688767)3月31日股东户数0.62万户,较上期减少2.11%
图解博拓生物一季报:第一季度单季净利润同比减77.97%
证券之星 · 04-25
图解博拓生物一季报:第一季度单季净利润同比减77.97%
图解博拓生物年报:第四季度单季净利润同比增432.59%
证券之星 · 04-25
图解博拓生物年报:第四季度单季净利润同比增432.59%
博拓生物04月25日主力净流出30万元 散户资金买入
市场透视 · 04-25
博拓生物04月25日主力净流出30万元 散户资金买入
博拓生物连续3个交易日缩量,缩量区间跌幅2.23%
金融界 · 04-25
博拓生物连续3个交易日缩量,缩量区间跌幅2.23%
博拓生物上涨7.15%,报40.77元/股
金融界 · 04-21
博拓生物上涨7.15%,报40.77元/股
博拓生物04月18日主力净流入62万元 散户资金抛售
市场透视 · 04-18
博拓生物04月18日主力净流入62万元 散户资金抛售
博拓生物04月16日主力净流出187万元 散户资金买入
市场透视 · 04-16
博拓生物04月16日主力净流出187万元 散户资金买入
博拓生物投资成立企管新公司
企查查财经 · 03-10
博拓生物投资成立企管新公司
中国脑机接口行业发展与展望:医疗器械专题之脑机接口
华安证券股份有... · 03-03
中国脑机接口行业发展与展望:医疗器械专题之脑机接口
博拓生物涨5%创近1年新高
智选洞察 · 03-03
博拓生物涨5%创近1年新高
加载更多
公司概况
公司名称:
杭州博拓生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2021-09-08
主营业务:
杭州博拓生物科技股份有限公司主营业务是POCT诊断试剂的研发、生产和销售。主要产品为生殖健康快速检测试剂-棒型、生殖健康、毒品、传染病、心肌、肿瘤快速检测试剂-滴板型、生殖健康、毒品、传染病快速检测试剂条型、毒品快速检测试剂插板型、毒品快速检测试剂杯型等。公司相继被认定为浙江省“专精特新”企业、“浙江省企业技术中心”。
发行价格:
34.55
{"stockData":{"symbol":"688767","market":"SH","secType":"STK","nameCN":"博拓生物","latestPrice":42.77,"timestamp":1746774001000,"preClose":40.8,"halted":0,"volume":1991766,"delay":0,"changeRate":0.0483,"floatShares":107000000,"shares":107000000,"eps":1.2996,"marketStatus":"已收盘","change":1.97,"latestTime":"05-09 15:00:01","open":41,"high":43.05,"low":40.5,"amount":84327600,"amplitude":0.0625,"askPrice":42.77,"askSize":79,"bidPrice":42.72,"bidSize":2,"shortable":0,"etf":0,"ttmEps":1.2996,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":40.8,"symbolType":"stock_kcb","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":44.88,"lowLimit":36.72,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":106666667,"isCdr":false,"pbRate":1.88,"roa":"--","peRate":32.910126,"roe":"0.36%","epsLYR":1.61,"committee":-0.41129,"marketValue":4562000000,"turnoverRate":0.0187,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-05-12。","afterMarket":{"amount":0,"volume":0,"close":42.77,"buyVolume":0,"sellVolume":0,"time":1746776038029,"indexStatus":"已收盘 05-09 15:30:00","preClose":40.8},"floatMarketCap":4562000000},"requestUrl":"/m/hq/s/688767","defaultTab":"news","newsList":[{"id":"2534144882","title":"博拓生物涨5%创近2年新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2534144882","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534144882?lang=zh_cn&edition=full","pubTime":"2025-05-09 13:17","pubTimestamp":1746767834,"startTime":"0","endTime":"0","summary":"05月09日,博拓生物股价大幅上涨,截至13点17分,博拓生物上涨5.05%,报42.86元/股,创近2年新高,成交5601万元,换手率1.25%。资金动向截止发稿,博拓生物获得主力净流出228万元,其中超大单流入281万元,大单流出509万元。主营业务及业绩博拓生物公司主营业务为从事POCT诊断试剂的研发、生产和销售。最新财报显示,今年一季报,博拓生物实现营业收入8,788.67万元,同比减少35.20%,净利润为873.24万元,同比减少77.97%,基本每股收益为0.08元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050913172397541917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050913172397541917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2533984195","title":"博拓生物:5月6日高管高红梅减持股份合计6000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533984195","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533984195?lang=zh_cn&edition=full","pubTime":"2025-05-07 20:02","pubTimestamp":1746619354,"startTime":"0","endTime":"0","summary":"证券之星消息,根据5月7日市场公开信息、上市公司公告及交易所披露数据整理,博拓生物最新董监高及相关人员股份变动情况:2025年5月6日公司董事,高级管理人员高红梅共减持公司股份6000.0股,占公司总股本为0.0056%。博拓生物近半年内的董监高及核心技术人员增减持详情如下:博拓生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入592.63万,融资余额增加;融券净流入0.0,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050700032533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2533026686","title":"博拓生物05月06日主力净流入313.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533026686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533026686?lang=zh_cn&edition=full","pubTime":"2025-05-06 15:20","pubTimestamp":1746516056,"startTime":"0","endTime":"0","summary":"05月06日, 博拓生物股价涨2.83%,报收40.02元,成交金额8080.8万元,换手率1.92%,振幅6.01%,量比2.55。博拓生物今日主力资金净流入313.5万元,上一交易日主力净流出851.6万元。该股主力净额占比0.07%,A股市场排名1509/5411,高于行业平均值。|05月06日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST奥维|9.50%|#|*ST智胜|8.25%|#|天和磁材|6.83%|#|...|...|#1509|博拓生物|0.07%|博拓生物所在的医疗器械行业,今日主力净流出1.44亿元,行业排名8/124。净流出前三个股分别为联影医疗、惠泰医疗、热景生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506165358a473c2ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506165358a473c2ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2531763467","title":"迈瑞首现营收净利双降,医疗器械黄金十年终结?","url":"https://stock-news.laohu8.com/highlight/detail?id=2531763467","media":"CHC医疗传媒","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531763467?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:05","pubTimestamp":1745971535,"startTime":"0","endTime":"0","summary":"4月28日,迈瑞医疗公布2024年报和2025年第一季度报告,现2018年以来首次季度营收和净利同比双降。众所周知,迈瑞以监护仪起家,生命信息与支持业务一直是其当家支柱。其中迈瑞位居第一名,占比59.51%;科曼、理邦、飞利浦、GE医疗同为品牌销售排行榜前五企业。以迈瑞2024年业绩为分割线,可能意味着医疗器械行业一个高体量、高增速时代的终结。众所周知,迈瑞医疗的目标是挺近全球医疗器械20强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430133918a46d3356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430133918a46d3356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688301","688581","159883","603301","688075","605369","688607","688198","688151","688273","688013","688217","688575","688212","600587","688338","603309","603987","603658","600529","688253","688366","688108","688410","159831","688317","603976","688677","688161","688389","688026","688613","688767","688617","600645","688067","603205","600055","688050"],"gpt_icon":0},{"id":"2531271043","title":"博拓生物04月29日主力净流入46万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2531271043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531271043?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:20","pubTimestamp":1745911222,"startTime":"0","endTime":"0","summary":"04月29日, 博拓生物股价涨0.23%,报收39.30元,成交金额2758.4万元,换手率0.65%,振幅3.55%,量比0.88。博拓生物今日主力资金净流入46万元,上一交易日主力净流出226万元。该股近5个交易日下跌3.77%,主力资金累计净流出62万元;近20日主力资金累计净流出3031万元,其中净流出天数为11日。|04月29日主力加仓幅度排名||#|股票简称|主力净额占比|#|红墙股份|7.84%|#|塞力医疗|6.27%|#|东珠生态|5.34%|#|...|...|#1910|博拓生物|0.01%|博拓生物所在的医疗器械行业,今日主力净流出1.78亿元,行业排名22/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429163858a46bc559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429163858a46bc559&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2530188458","title":"博拓生物:2024年业绩斩获高增长,产业布局未来可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2530188458","media":"览富财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530188458?lang=zh_cn&edition=full","pubTime":"2025-04-27 20:47","pubTimestamp":1745758036,"startTime":"0","endTime":"0","summary":"博拓生物始终坚持技术驱动增长,2024年研发费用投入为6357.46万元,占营业收入的11.36%。根据报告,博拓生物还提请股东大会授权制定2025年中期分红方案,以便在满足中期分红的条件下,能够根据其与市场情况,更加灵活地制定和实施中期分红。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042720474094e4b764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042720474094e4b764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2530851304","title":"博拓生物2024年归母净利润增59%至1.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530851304","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530851304?lang=zh_cn&edition=full","pubTime":"2025-04-27 13:56","pubTimestamp":1745733376,"startTime":"0","endTime":"0","summary":"4月25日,博拓生物公布2024年年报,公司营业收入为5.59亿元,同比上升26.5%;归母净利润为1.7亿元,同比上升59%;扣非归母净利润为1.19亿元,同比上升50.2%;经营现金流净额为1.29亿元,同比下降1.9%;EPS为1.5892元。其中第四季度,公司营业收入为1.71亿元,同比上升31.4%;归母净利润为8030万元,同比上升432.6%;扣非归母净利润为3814万元,同比上升968.5%;EPS为0.7528元。截至四季度末,公司总资产26.02亿元,较上年度末增长0.9%;归母净资产为24.09亿元,较上年度末下降0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042713571397470a8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042713571397470a8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767"],"gpt_icon":0},{"id":"2530172498","title":"博拓生物(688767)2025年一季报简析:净利润减77.97%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2530172498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530172498?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:24","pubTimestamp":1745706242,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期博拓生物发布2025年一季报。截至本报告期末,公司营业总收入8788.67万元,同比下降35.2%,归母净利润873.24万元,同比下降77.97%。本报告期博拓生物三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达7540.56%。然而去年的净利率为29.81%,算上全部成本后,公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700001293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"gpt_icon":0},{"id":"2530144786","title":"博拓生物(688767)3月31日股东户数0.62万户,较上期减少2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530144786","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530144786?lang=zh_cn&edition=full","pubTime":"2025-04-26 17:08","pubTimestamp":1745658490,"startTime":"0","endTime":"0","summary":"证券之星消息,近日博拓生物披露,截至2025年3月31日公司股东户数为6212.0户,较12月31日减少134.0户,减幅为2.11%。在医疗器械行业个股中,博拓生物股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.09万户。从股价来看,2024年12月31日至2025年3月31日,博拓生物区间涨幅为19.31%,在此期间股东户数减少134.0户,减幅为2.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600011482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2530816503","title":"图解博拓生物一季报:第一季度单季净利润同比减77.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530816503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530816503?lang=zh_cn&edition=full","pubTime":"2025-04-26 02:12","pubTimestamp":1745604737,"startTime":"0","endTime":"0","summary":"证券之星消息,博拓生物2025年一季报显示,公司主营收入8788.67万元,同比下降35.2%;归母净利润873.24万元,同比下降77.97%;扣非净利润637.45万元,同比下降83.84%;负债率4.7%,投资收益194.07万元,财务费用-848.7万元,毛利率46.18%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600000861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"gpt_icon":0},{"id":"2530683011","title":"图解博拓生物年报:第四季度单季净利润同比增432.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530683011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530683011?lang=zh_cn&edition=full","pubTime":"2025-04-26 00:59","pubTimestamp":1745600359,"startTime":"0","endTime":"0","summary":"证券之星消息,博拓生物2024年年报显示,公司主营收入5.59亿元,同比上升26.53%;归母净利润1.7亿元,同比上升59.01%;扣非净利润1.19亿元,同比上升50.19%;其中2024年第四季度,公司单季度主营收入1.71亿元,同比上升31.38%;单季度归母净利润8030.37万元,同比上升432.59%;单季度扣非净利润3813.88万元,同比上升968.45%;负债率7.29%,投资收益678.98万元,财务费用-6007.27万元,毛利率52.84%。财报数据概要请见下图:","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426010516a46713a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426010516a46713a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767"],"gpt_icon":0},{"id":"2530908157","title":"博拓生物04月25日主力净流出30万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2530908157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530908157?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:21","pubTimestamp":1745565695,"startTime":"0","endTime":"0","summary":"04月25日, 博拓生物股价跌0.35%,报收39.88元,成交金额2216万元,换手率0.52%,振幅3.47%,量比0.58。博拓生物今日主力资金净流出30万元,上一交易日主力净流入130万元。该股近5个交易日上涨4.81%,主力资金累计净流出1205万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流出2266万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425162118a6c7beea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425162118a6c7beea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2530975186","title":"博拓生物连续3个交易日缩量,缩量区间跌幅2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530975186","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530975186?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:05","pubTimestamp":1745564752,"startTime":"0","endTime":"0","summary":"截至4月25日收盘,博拓生物报39.88元,下跌0.35%,成交76.69万股,成交量连续3个交易日缩量,缩量区间跌幅2.23%。资料显示,杭州博拓生物科技股份有限公司主营业务是POCT诊断试剂的研发、生产和销售。主要产品为生殖健康快速检测试剂-棒型、生殖健康、毒品、传染病、心肌、肿瘤快速检测试剂-滴板型、生殖健康、毒品、传染病快速检测试剂条型、毒品快速检测试剂插板型、毒品快速检测试剂杯型等。公司相继被认定为浙江省“专精特新”企业、“浙江省企业技术中心”。资金流方面,博拓生物当日主力资金净流入67.94万元。责任编辑:磐石","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042515143994e21818&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042515143994e21818&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2529152814","title":"博拓生物上涨7.15%,报40.77元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529152814","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529152814?lang=zh_cn&edition=full","pubTime":"2025-04-21 10:20","pubTimestamp":1745202003,"startTime":"0","endTime":"0","summary":"4月21日,博拓生物盘中上涨7.15%,截至10:20,报40.77元/股,成交3981.2万元,换手率0.94%,总市值43.49亿元。截至9月30日,博拓生物股东户数7239,人均流通股1.47万股。2024年1月-9月,博拓生物实现营业收入3.89亿元,同比增长24.51%;归属净利润8921.17万元,同比减少2.53%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/21102049699621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2528603248","title":"博拓生物04月18日主力净流入62万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2528603248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528603248?lang=zh_cn&edition=full","pubTime":"2025-04-18 15:20","pubTimestamp":1744960859,"startTime":"0","endTime":"0","summary":"04月18日, 博拓生物股价涨2.53%,报收38.05元,成交金额2276万元,换手率0.56%,振幅2.94%,量比0.78。博拓生物今日主力资金净流入62万元,上一交易日主力净流出94万元。该股近5个交易日下跌1.04%,主力资金累计净流出739万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出427万元,其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418162215a6bf0ec7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418162215a6bf0ec7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2527266742","title":"博拓生物04月16日主力净流出187万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527266742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527266742?lang=zh_cn&edition=full","pubTime":"2025-04-16 15:22","pubTimestamp":1744788120,"startTime":"0","endTime":"0","summary":"04月16日, 博拓生物股价跌2.48%,报收37.03元,成交金额2016万元,换手率0.51%,振幅3.08%,量比0.62。博拓生物今日主力资金净流出187万元,上一交易日主力净流入10万元。该股近5个交易日上涨4.87%,主力资金累计净流出298万元;近20日主力资金累计净流出397万元,其中净流出天数为9日。|04月16日主力加仓幅度排名||#|股票简称|主力净额占比|#|N肯特|19.77%|#|亚联机械|7.56%|#|健尔康|6.15%|#|...|...|#2718|博拓生物|-0.05%|博拓生物所在的医疗器械行业,今日主力净流出2.44亿元,行业排名49/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416170920a45ae0e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416170920a45ae0e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2518832247","title":"博拓生物投资成立企管新公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2518832247","media":"企查查财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518832247?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:59","pubTimestamp":1741636754,"startTime":"0","endTime":"0","summary":"企查查APP显示,近日,杭州博肽智投企业管理有限公司成立,法定代表人为费其俊,注册资本1亿元,经营范围包含:非居住房地产租赁;园区管理服务;企业管理咨询等。企查查股权穿透显示,该公司由博拓生物(688767)全资持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311040122a26abc04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311040122a26abc04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2516942276","title":"中国脑机接口行业发展与展望:医疗器械专题之脑机接口","url":"https://stock-news.laohu8.com/highlight/detail?id=2516942276","media":"华安证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516942276?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:00","pubTimestamp":1741017600,"startTime":"0","endTime":"0","summary":"政策引导+技术突破,全球脑机接口产业进入高速发展阶段,中国非侵入式脑机接口技术全球领先。中国围绕非侵入式脑机接口方向,实现弯道超车,首创实现“双环路”脑机交互系统,打破了传统脑机接口的信息交互,并极大突破了操控时间的限制,该技术突破使得中国在非侵入式脑机接口领域处于全球领先地位。医疗健康是当前脑机接口最成熟的赛道,覆盖神经疾病诊断、康复治疗及功能替代。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","603987","688212","688389","688426","688068","688767","688013","688085","688351","688151","BK0114","688606","600529","688338","600587","688580","688581","688317","688217","600645","603309","688050","688193","688253","688271","688277","688358","688575","603205","688607","603301","600055","688161","BK0251","688273","688468","688114","603222","688298","688656","688399","600807","688289","688075","688139","688576","605369","688366","688677","688301","BK0146","688236","159883","688029","688026","688198","688626","603880","603976","688410","603387","603658","688314","BK0070","688393","688617","688108","688067","688613"],"gpt_icon":0},{"id":"2516266520","title":"博拓生物涨5%创近1年新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2516266520","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516266520?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:31","pubTimestamp":1740969100,"startTime":"0","endTime":"0","summary":"03月03日,博拓生物股价大幅上涨,截至10点31分,博拓生物上涨5.01%,报37.28元/股,创近1年新高,成交3482万元,换手率0.89%,振幅5.01%。资金动向截止发稿,博拓生物获得主力净流出190万元,其中超大单流出153万元,大单流出36万元。最新财报显示,今年三季报,博拓生物实现营业收入3.89亿元,同比增长24.51%,净利润为8,921.17万元,同比减少2.53%,基本每股收益为0.85元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303103159abe5497a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303103159abe5497a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746909040461,"stockEarnings":[{"period":"1week","weight":0.0989},{"period":"1month","weight":0.2113},{"period":"3month","weight":0.2535},{"period":"6month","weight":0.4187},{"period":"1year","weight":0.4507},{"period":"ytd","weight":0.3152}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州博拓生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6212人(较上一季度减少2.11%)","perCapita":"17171股","listingDate":"2021-09-08","address":"浙江省杭州市余杭区中泰街道富泰路17号","registeredCapital":"10666万元","survey":" 杭州博拓生物科技股份有限公司主营业务是POCT诊断试剂的研发、生产和销售。主要产品为生殖健康快速检测试剂-棒型、生殖健康、毒品、传染病、心肌、肿瘤快速检测试剂-滴板型、生殖健康、毒品、传染病快速检测试剂条型、毒品快速检测试剂插板型、毒品快速检测试剂杯型等。公司相继被认定为浙江省“专精特新”企业、“浙江省企业技术中心”。","listedPrice":34.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博拓生物,688767,博拓生物股票,博拓生物股票老虎,博拓生物股票老虎国际,博拓生物行情,博拓生物股票行情,博拓生物股价,博拓生物股市,博拓生物股票价格,博拓生物股票交易,博拓生物股票购买,博拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}